 postop hypertens prospect placebo-control double-blind trial intraven nicardipin hydrochlorid nicardipin hydrochlorid new calcium channel blocker intraven use placebo prospect double-blind trial postop hypertens patient preoper consent entri criteria hypertens nicardipine-tr patient placebo placebo failur nicardipin signific complic group author nicardipin effect safe therapi postop hypertens further studi indic drug condit